IMPACTFUL CARDIOVASCULAR TRIALS IN THE LAST DECADE

Gemma Figtree is a professor of medicine at The University of Sydney, Australia.

Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.

An interventional cardiology at National Heart Centre Singapore, Singapore. Features in 29 videos on Wondr Medical. Jack Tan generally speaks on Covid-19, Covid19 Webinars and Discussions, Artificial Intelligence (Cardiology), Biomarkers, and Diabetes.

Dr. Lee is currently an Associate Professor of Medicine, Associate Chief of the Division of Cardiology and Interim Director of the Cardiovascular Service Line at Banner University Medicine in Tucson. He joined the Sarver Heart Center at the Universtiy of Arizona in 2009 and is a board certified interventional cardiologist. Originally from Malaysia, he earned his medical degree from Trinity College, Dublin, Ireland, graduating in 2000. He completed his internship at St James's Hospital in Dublin, Ireland, then moved to the Mayo Clinic, Scottsdale, Arizona, where he completed his internal medicine residency and cardiology fellowship. He went on to an interventional cardiology fellowship at Emory University Hospital in Atlanta. Dr. Lee has pursued several areas of research, including work in Optical Coherence Tomography, echocardiography and simulation in cardiovascular training. He writes a regular blog on TCTMD, "Off Script" and is currently the American College of Cardiology Arizona Chapter governor. He is the co-course director of the only state-wide quarterly cardiology fellowship simulation course in the US and has spoken at many national and international meetings.